Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bayer AG buy Lutz69

Start price
€50.08
24.01.22 / 50%
Target price
-
24.01.26
Performance (%)
-47.43%
End price
€26.33
11.03.24
Summary
This prediction ended on 11.03.24 with a price of €26.33. Massive losses of -47.43% were the result for the BUY prediction by Lutz69. Dividends of €4.76 are taken into consideration when calculating the performance. Lutz69 has 50% into this prediction

Bayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.

Performance without dividends (%)
Name 1w 1m 1y
Bayer AG 2.664% 2.664% -55.184%
iShares Core DAX® 1.051% -1.833% 12.822%
iShares Nasdaq 100 -0.547% -3.738% 40.625%
iShares Nikkei 225® -1.778% -8.115% 16.092%
iShares S&P 500 0.002% -2.226% 28.387%

According to Lutz69 what are the pros and cons of Bayer AG for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by Lutz69 for this prediction

In the thread Bayer AG diskutieren

Buy Bayer AG

Stopped prediction by Lutz69 for Bayer AG

Bayer AG

Start price
Target price
Perf. (%)
€44.38
19.10.20
-
04.11.21
8.60%
16.11.20

Could be worthwhile Investment >10% per year
buy
Bayer AG

Start price
Target price
Perf. (%)
€58.89
24.04.20
€80.00
19.10.20
-24.65%
19.10.20

Could be worthwhile Investment >10% per year